Kodiak Sciences Inc.
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that …
Biotechnology
US, Palo Alto [HQ]
Revenue Breakdowns
Segment Analysis Beta
The financial segments are sourced from the SEC' 10-K statement.Revenue By Top Segments
Kodiak Sciences Inc. can't present it's sankey chart.
Historical Revenue By Segment
Last 3Y, in million USDKodiak Sciences Inc. can't present revenue by segment
Get PRO Today
With PRO you can bypass the blur for the segment revenues of Kodiak Sciences Inc..
If you want to see a demo, head over to the financial segments of AAPL